Abstract:Objective To identify the clinical features of severe scrub typhus patients . Methods A total of 66 patients with scrub typhus who were admitted into Ganzhou Renmin Hospital from July 2011 to October 2013 were enrolled.According to the diagnostic criterion of severe disease , the patients were divided into two groups: severe group ( n=29) and non -severe group ( n =37).Comparison was made between the two groups in clinical manifestation , laboratory examination, imageology examination, treatment and prognosis.Results Severe group was higher (P <0.05) than non -severe group in the incidence of dyspnea , palpitation , lower limb edema , rale in lung and hypotension .The incidence of eschar was 97.0%.Severe group was lower ( P<0.05 ) in the levels of PLT and Alb and higher ( P<0.05 ) in the levels of Scr , BUN, ALT, AST, TBiL, CK, CK-MB, LDH and PCT than non -severe group.Severe group was also higher ( P<0.05 ) than non-severe group in the incidence of the ratio inversion of ALT /AST.Weil-Felix OXK reaction was tested within one week after onset, with a positive rate of 14.7% (5/34).Through the chest X -ray examination conducted on all subjects in severe group, we noted inflammatory exudation in 28 ( 96.6%) subjects and unilateral or bilateral pleural effusion in 22 ( 75.9%) subjects.Chest X-ray examination was conducted on 31 subjects in non -severe group , by which we noted inflammatory exudation in 19 (61.3%) subjects and change of pleural effusion in 13 (41.9%) subjects.Severe group was higher ( P<0.05) than non-severe group in the incidence of inflammatory exudation and pleural effusion .In severe group, 10 (34.5%) subjects had hepatomegaly , 19 ( 65.5%) subjects had splenauxe , 8 ( 27.6%) subjects had seroperitoneum .In non -severe group, 9 ( 24.3%) subjects had hepatomegaly , 20 ( 54.1%) subjects had splenauxe , 5 ( 13.5%) subjects had seroperitoneum.The two groups had no significant difference (P>0.05) in hepatomegaly, splenauxe and seroperitoneum.After diagnosis, the subjects were treated with doxycycline and tetracycline .The time need for abating fever was (4.3 ±2.2) d for severe group, longer (P<0.05) than that of non-severe group which was (2.7 ±1.8) d.Conclusion Severe scrub typhus patients are significantly different from non -severe scrub typhus patients in the incidence of dyspnea , palpitation , lower limb edema, rale in lung and hypotension , in the levels of PLT, Alb, Scr, BUN, ALT, AST, TBiL, CK, CK-MB, LDH and PCT and in the incidence of the ratio reversion of ALT/AST.Severe scrub typhus patients are more likely to have double lung involvement , pleural effusion and longer time need for abating fever .Severe scrub typhus patients should be closely monitored and treated actively in order to reduce case fatality rate .

Clinical and laboratory findings in scrub typhus associated Guillain‐Barré syndrome in South Korea

Guillain-Barré syndrome in southern China: retrospective analysis of hospitalised patients from 14 provinces in the area south of the Huaihe River.

Clinical features and validation of Brighton criteria in Guillain-Barré syndrome in southern China:retrospective analysis of 1358 hospitalized patients in four years

Guillain–Barre syndrome following scrub typhus: a case report and literature review

Guillain–Barré Syndrome After COVID-19 Infection in Korea: A Case Series

The analysis of misdiagnosis and mismanagement of 145 patients with Guillain-Barré syndrome in the emergency department

Current status of Guillain–Barré syndrome (GBS) in China: a 10-year comprehensive overview

Guillain Barre Syndrome as a Complication of COVID-19: A Systematic Review

Clinical Features of Severe Scrub Typhus Patients

Clinical Analysis of 48 Cases with Guillain-Barré Syndrome

Guillain-barré syndrome (GBS) with antecedent chikungunya infection: a case report and literature review

Guillain Barre syndrome with pulmonary tuberculosis: A case series from a tertiary care hospital

Clinical presentation and symptomatology of Guillain-Barré syndrome: A literature review

A 'Decrescendo' in a Woman With Ascending Paralysis: A Diagnostic Challenge

Guillain-Barre syndrome in 220 patients with COVID-19

Electrodiagnostic methods to verify Guillain‐Barré syndrome subtypes in Istanbul: A prospective multicenter study

Guillain-Barré Syndrome and Variants Following COVID-19 Vaccination: Report of 13 Cases

Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran

Covid-19 associated Guillain-Barré syndrome: A series of a relatively uncommon neurological complication

Clinical characteristics of Guillain–Barré syndrome in patients with primary Sjögren's syndrome

Guillain–Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases